These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8855848)

  • 1. Interferon therapy for hepatitis C.
    Preston H; Wright TL
    Lancet; 1996 Oct; 348(9033):973-4. PubMed ID: 8855848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hepatitis C: advances and consensus].
    Lerebours E; Marcellin P; Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic hepatitis C.
    Nelson DR; Davis GL
    Compr Ther; 1997 Apr; 23(4):269-76. PubMed ID: 9167919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?].
    Brenard R; Closon ML; Fevery J; Hautekeete M
    Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538
    [No Abstract]   [Full Text] [Related]  

  • 6. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract]   [Full Text] [Related]  

  • 7. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus conference. Treatment of hepatitis C.
    Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES)
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B303-20. PubMed ID: 12180305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of antiviral therapy in patients with advanced hepatitis C virus disease: still not there!
    Rubin A; Berenguer M
    Liver Transpl; 2010 Jun; 16(6):697-700. PubMed ID: 20517902
    [No Abstract]   [Full Text] [Related]  

  • 10. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
    European Association for the Study of the Liver
    J Hepatol; 2011 Aug; 55(2):245-64. PubMed ID: 21371579
    [No Abstract]   [Full Text] [Related]  

  • 11. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C: from pathogenesis to treatment].
    Delarive J; Berger JP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(45):1278-83. PubMed ID: 7505477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HCV genotype as a predictor of response to IFN therapy in chronic hepatitis C].
    Ebata M; Fukuda Y; Koyama Y; Hayakawa T; Kumada T; Nakano S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):954-8. PubMed ID: 7563909
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients.
    Lo Iacono O
    Rev Esp Enferm Dig; 2000 Aug; 92(8):485-94. PubMed ID: 11084816
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel interferons for treatment of hepatitis C virus.
    Clark V; Nelson DR
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy].
    Hino K; Murakami C; Fujii K; Okazaki M; Okuda M; Hanada H; Okita K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):949-53. PubMed ID: 7563907
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of glomerulonephritis associated with hepatitis C virus in patient with cirrhosis: only pegylated interferon and ribavirin.
    Taş A; Koçak E; Akbal E; Köklü S
    Chin Med J (Engl); 2011 May; 124(10):1600. PubMed ID: 21740828
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.